Citations (69)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Scott Graupensperger, Shane N. Sweet & M. Blair Evans. (2021) Multimorbidity of overweight and obesity alongside anxiety and depressive disorders in individuals with spinal cord injury. The Journal of Spinal Cord Medicine 44:6, pages 992-1000.
Read now
Read now
Yan Ma, Alicia Yeung, Albert C. Yang, Chung-Kang Peng, Alisabet Clain, Jonathan Alpert, Maurizio Fava & Albert S. Yeung. (2018) The Effects of Tai Chi on Sleep Quality in Chinese American Patients With Major Depressive Disorder: A Pilot Study. Behavioral Sleep Medicine 16:4, pages 398-411.
Read now
Read now
Richard Musil, Michael Obermeier, Paul Russ & Michael Hamerle. (2015) Weight gain and antipsychotics: a drug safety review. Expert Opinion on Drug Safety 14:1, pages 73-96.
Read now
Read now
Mehrul Hasnain & W. Victor R. Vieweg. (2013) Weight Considerations in Psychotropic Drug Prescribing and Switching. Postgraduate Medicine 125:5, pages 117-129.
Read now
Read now
Articles from other publishers (65)
David J. Robinson, Kimberley Hanson, Akshay B. Jain, Jessica C. Kichler, Gaurav Mehta, Osnat C. Melamed, Michael Vallis, Harpreet S. Bajaj, Tracy Barnes, Jeremy Gilbert, Kristin Honshorst, Robyn Houlden, James Kim, Joanne Lewis, Barbara MacDonald, Dylan MacKay, Kerry Mansell, Doreen Rabi, Diana Sherifali & Peter Senior. (2023) Diabetes and Mental Health. Canadian Journal of Diabetes 47:4, pages 308-344.
Crossref
Crossref
Marianna Piras, Setareh Ranjbar, Nermine Laaboub, Claire Grosu, Franziska Gamma, Kerstin Jessica Plessen, Armin von Gunten, Philippe Conus & Chin Bin Eap. (2023) Evolutions of Metabolic Parameters Following Switches of Psychotropic Drugs: A Longitudinal Cohort Study. Schizophrenia Bulletin 49:1, pages 24-33.
Crossref
Crossref
Gurjinder Kaur, Rajan Gaur & Kallur Nava Saraswathy. (2022) Somatotype Characteristics of a Mendelian Population from North India and Its association with Cognitive Impairment and Depression. The Oriental Anthropologist: A Bi-annual International Journal of the Science of Man 22:2, pages 278-292.
Crossref
Crossref
Sandra M. Christensen, Catherine Varney, Vivek Gupta, Lori Wenz & Harold Edward Bays. (2022) Stress, psychiatric disease, and obesity: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022. Obesity Pillars 4, pages 100041.
Crossref
Crossref
Merja K. Laine, Hannu Kautiainen, Mika Gissler, Pirjo Pennanen & Johan G. Eriksson. (2022) Drug purchases prior to conception and the risk of gestational diabetes mellitus. Journal of International Medical Research 50:11, pages 030006052211384.
Crossref
Crossref
Rachel R. Corrigan, Helen Piontkivska & Gemma Casadesus. (2022) Amylin Pharmacology in Alzheimer’s Disease Pathogenesis and Treatment. Current Neuropharmacology 20:10, pages 1894-1907.
Crossref
Crossref
Justin Tondt & Harold Edward Bays. (2022) Concomitant medications, functional foods, and supplements: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022. Obesity Pillars 2, pages 100017.
Crossref
Crossref
Emilia Vassilopoulou, Dimitris Efthymiou, Evangelia Papatriantafyllou, Maria Markopoulou, Efthymia-Maria Sakellariou & Alina-Codruța Popescu. (2022) Long-term metabolic and inflammatory effects of second-generation antipsychotics: A study in mentally disordered offenders. Public Health and Toxicology 2:Supplement 1.
Crossref
Crossref
HaniH Dessoki & MohamedR Soltan. (2022) Atypical antipsychotics in major depressive disorder. Egyptian Journal of Psychiatry 43:1, pages 7.
Crossref
Crossref
Simone Schimmenti, Francesca Maria Camilla Maselli & Sarah Tosato. 2022. Prevention in Mental Health. Prevention in Mental Health
225
249
.
Johanna Roponen, Anu Ruusunen, Pilvikki Absetz, Timo Partonen, Virpi Kuvaja-Köllner, Mika Hujo & Outi Nuutinen. (2021) Nutrition-focused group intervention with a strength-based counseling approach for people with clinical depression: a study protocol for the Food for Mind randomized controlled trial. Trials 22:1.
Crossref
Crossref
Emilia Vassilopoulou, Dimitris Efthymiou, Evangelia Papatriantafyllou, Maria Markopoulou, Efthymia-Maria Sakellariou & Alina Codruta Popescu. (2021) Long Term Metabolic and Inflammatory Effects of Second-Generation Antipsychotics: A Study in Mentally Disordered Offenders. Journal of Personalized Medicine 11:11, pages 1189.
Crossref
Crossref
Hua Luo, Zheng-Li Jiang & Yu Ren. (2021) Therapy Management of Metabolic Disorder Comorbidity With Depression. Frontiers in Psychology 12.
Crossref
Crossref
Geng-Ruei Chang, Hsien-Yueh Liu, Wei-Cheng Yang, Chao-Min Wang, Ching-Fen Wu, Jen-Wei Lin, Wei-Li Lin, Yu-Chen Wang, Tzu-Chun Lin, Huei-Jyuan Liao, Po-Hsun Hou, Chee-Hong Chan & Chuen-Fu Lin. (2021) Clozapine Worsens Glucose Intolerance, Nonalcoholic Fatty Liver Disease, Kidney Damage, and Retinal Injury and Increases Renal Reactive Oxygen Species Production and Chromium Loss in Obese Mice. International Journal of Molecular Sciences 22:13, pages 6680.
Crossref
Crossref
Ilker Ozsahin, Mubarak T Mustapha, Safa Albarwary, Burcin Sanlidag, Dilber Uzun Ozsahin & Tracy A Butler. (2021) An investigation to choose the proper therapy technique in the management of autism spectrum disorder. Journal of Comparative Effectiveness Research 10:5, pages 423-437.
Crossref
Crossref
Francisco T. T. Lai, Bruce Guthrie, Stewart W. Mercer, Daniel J. Smith, Benjamin H. K. Yip, Gary K. K. Chung, Kam-Pui Lee, Roger Y. Chung, Patsy Y. K. Chau, Eliza L. Y. Wong, Eng-Kiong Yeoh & Samuel Y. S. Wong. (2020) Association between antipsychotic use and acute ischemic heart disease in women but not in men: a retrospective cohort study of over one million primary care patients. BMC Medicine 18:1.
Crossref
Crossref
Michael Schneider, Philipp Pauwels, Sermin Toto, Stefan Bleich, Renate Grohmann, Martin Heinze & Timo Greiner. (2020) Severe weight gain as an adverse drug reaction of psychotropics: Data from the AMSP project between 2001 and 2016. European Neuropsychopharmacology 36, pages 60-71.
Crossref
Crossref
Xiao‐Qin Wan, Fan Zeng, Xu‐Feng Huang, He‐Qin Yang, Lan Wang, Yan‐Chuan Shi, Zhi‐Hui Zhang & Shu Lin. (2019) Risperidone stimulates food intake and induces body weight gain via the hypothalamic arcuate nucleus 5‐HT2c receptor—NPY pathway. CNS Neuroscience & Therapeutics 26:5, pages 558-566.
Crossref
Crossref
Jin Ryeol An, Mi Seon Seo, Hee Seok Jung, Hongliang Li, Won-Kyo Jung, Il-Whan Choi, Kwon-Soo Ha, Eun-Taek Han, Seok-Ho Hong, Hongzoo Park, Young Min Bae & Won Sun Park. (2020) Inhibition by the atypical antipsychotic risperidone of voltage-dependent K+ channels in rabbit coronary arterial smooth muscle cells. European Journal of Pharmacology 874, pages 173027.
Crossref
Crossref
Renee-Marie Ragguett & Roger S. McIntyre. 2020. Schizophrenia Treatment Outcomes. Schizophrenia Treatment Outcomes
197
203
.
Yuanzhong Xu, Yungang Lu, Ryan M. Cassidy, Leandra R. Mangieri, Canjun Zhu, Xugen Huang, Zhiying Jiang, Nicholas J. Justice, Yong Xu, Benjamin R. Arenkiel & Qingchun Tong. (2019) Identification of a neurocircuit underlying regulation of feeding by stress-related emotional responses. Nature Communications 10:1.
Crossref
Crossref
Anna Wasik, Anna Krupa & Marcin Siwek. (2019) Interactions of antidepressants, mood-stabilisers and antipsychotics with food. Pharmacotherapy in Psychiatry and Neurology 35:1, pages 51-74.
Crossref
Crossref
Olivia Currie, Jonathan Williman, Dee Mangin, Bianca McKinnon-Gee & Paul Bridgford. (2019) Comparative risk of new-onset diabetes following commencement of antipsychotics in New Zealand: a population-based clustered multiple baseline time series design. BMJ Open 9:2, pages e022984.
Crossref
Crossref
Amitai Abramovitch, Gideon E. Anholt, Allison Cooperman, Anton J.L.M. van Balkom, Erik J. Giltay, Brenda W. Penninx & Patricia van Oppen. (2019) Body mass index in obsessive-compulsive disorder. Journal of Affective Disorders 245, pages 145-151.
Crossref
Crossref
Lei Zheng, Lixia Yang, Xin Zhao, Niya Long, Peifan Li & Yiming Wang. (2019) Effect of risperidone on proliferation and apoptosis of MC3T3-E1 cells. Brazilian Journal of Medical and Biological Research 52:3.
Crossref
Crossref
. 2019. Therapie psychischer Erkrankungen. Therapie psychischer Erkrankungen
1
119
.
Leon I. Igel. 2019. Obesity Management. Obesity Management
61
67
.
Vasiliki Mamakou, Ioanna Eleftheriadou, Anastasios Tentolouris, Nikolaos Sabanis, Aikaterini Drylli & Nikolaos Tentolouris. (2018) Diabetogenic Effects Associated with Psychiatric Treatment. Current Pharmacology Reports 4:2, pages 103-111.
Crossref
Crossref
Florent Auger, Françoise Martin, Olivier Pétrault, Jennifer Samaillie, Thierry Hennebelle, Mohamed-Sami Trabelsi, François Bailleul, Bart Staels, Régis Bordet & Patrick Duriez. (2017) Risperidone-induced metabolic dysfunction is attenuated by Curcuma longa extract administration in mice. Metabolic Brain Disease 33:1, pages 63-77.
Crossref
Crossref
K.K. Fjukstad, A. Engum, S. Lydersen, I. Dieset, N. Eiel Steen, O.A. Andreassen & O. Spigset. (2020) Metabolic risk factors in schizophrenia and bipolar disorder: The effect of comedication with selective serotonin reuptake inhibitors and antipsychotics. European Psychiatry 48:1, pages 71-78.
Crossref
Crossref
Laura Orsolini, Federica Vellante, Alessandro Valchera, Michele Fornaro, Alessandro Carano, Maurizio Pompili, Giampaolo Perna, Gianluca Serafini, Marco Di Nicola, Giovanni Martinotti, Massimo Di Giannantonio & Domenico De Berardis. 2018. Understanding Depression. Understanding Depression
257
268
.
Leon I. Igel, Rekha B. Kumar, Katherine H. Saunders & Louis J. Aronne. (2017) Practical Use of Pharmacotherapy for Obesity. Gastroenterology 152:7, pages 1765-1779.
Crossref
Crossref
Ana SayuriYamagata, Elisa Brietzke, Joshua D. Rosenblat, Ron Kakar & Roger S. McIntyre. (2017) Medical comorbidity in bipolar disorder: The link with metabolic-inflammatory systems. Journal of Affective Disorders 211, pages 99-106.
Crossref
Crossref
. 2017. Therapie psychischer Erkrankungen. Therapie psychischer Erkrankungen
1
111
.
Joseph J. Sabia, Jeffrey Swigert & Timothy Young. (2017) The Effect of Medical Marijuana Laws on Body Weight. Health Economics 26:1, pages 6-34.
Crossref
Crossref
Katrine Kveli Fjukstad, Anne Engum, Stian Lydersen, Ingrid Dieset, Nils Eiel Steen, Ole A. Andreassen & Olav Spigset. (2016) Metabolic Abnormalities Related to Treatment With Selective Serotonin Reuptake Inhibitors in Patients With Schizophrenia or Bipolar Disorder. Journal of Clinical Psychopharmacology 36:6, pages 615-620.
Crossref
Crossref
Mehrul Hasnain. (2016) Schizophrenia and metabolic dysregulation: shared roots?. The Lancet Psychiatry 3:11, pages 1003-1005.
Crossref
Crossref
Virginio Salvi, Claudio Mencacci & Francesco Barone-Adesi. (2016) H1-histamine receptor affinity predicts weight gain with antidepressants. European Neuropsychopharmacology 26:10, pages 1673-1677.
Crossref
Crossref
Nilesh Shah, M.S. Reddy, Sandeep Vohra, Uday Chaudhuri & Senthilnathan Mohanasundaram. (2016) Safety and effectiveness of divalproex sodium extended release containing regimen in Indian patients with bipolar I disorder in continuation phase: Results of EASED registry. Asian Journal of Psychiatry 20, pages 32-38.
Crossref
Crossref
Harold E. Bays, Peter H. Jones, Carl E. Orringer, W. Virgil Brown & Terry A. Jacobson. (2016) National Lipid Association Annual Summary of Clinical Lipidology 2016. Journal of Clinical Lipidology 10:1, pages S1-S43.
Crossref
Crossref
Mehrul Hasnain. (2015) Genetic vulnerability in antipsychotic drug-induced diabetes. The Lancet Psychiatry 2:12, pages 1049-1051.
Crossref
Crossref
Carmen E. Gota, Sahar Kaouk & William S. Wilke. (2015) Fibromyalgia and Obesity. JCR: Journal of Clinical Rheumatology 21:6, pages 289-295.
Crossref
Crossref
Priyadarshini P. Ravindran, Wenzhao Zang, Swetha Renukunta, Rick Mansour & Srinivas Denduluri. (2015) Effect of comedication of bupropion and other antidepressants on body mass index. Therapeutic Advances in Psychopharmacology 5:3, pages 158-165.
Crossref
Crossref
Christoph U. Correll, Johan Detraux, Jan De Lepeleire & Marc De Hert. (2015) Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder. World Psychiatry 14:2, pages 119-136.
Crossref
Crossref
David C Henderson, Brenda Vincenzi, Nicolas V Andrea, Melissa Ulloa & Paul M Copeland. (2015) Pathophysiological mechanisms of increased cardiometabolic risk in people with schizophrenia and other severe mental illnesses. The Lancet Psychiatry 2:5, pages 452-464.
Crossref
Crossref
Christopher J. Lynch, Yuping Xu, Andras Hajnal, Anna C. Salzberg & Yuka Imamura Kawasawa. (2015) RNA Sequencing Reveals a Slow to Fast Muscle Fiber Type Transition after Olanzapine Infusion in Rats. PLOS ONE 10:4, pages e0123966.
Crossref
Crossref
. 2015. Therapie Psychischer Erkrankungen. Therapie Psychischer Erkrankungen
e1
e96
.
Mythily Subramaniam, Amy See Yuning, Janhavi Ajit Vaingankar & Siow Ann Chong. 2015. Heart and Toxins. Heart and Toxins
275
303
.
Rituparna Bhattacharya, Chan Shen & Usha Sambamoorthi. (2014) Excess risk of chronic physical conditions associated with depression and anxiety. BMC Psychiatry 14:1.
Crossref
Crossref
David E. Kemp. (2014) Managing the side effects associated with commonly used treatments for bipolar depression. Journal of Affective Disorders 169, pages S34-S44.
Crossref
Crossref
Jason C. D. Nguyen, A. Simon Killcross & Trisha A. Jenkins. (2014) Obesity and cognitive decline: role of inflammation and vascular changes. Frontiers in Neuroscience 8.
Crossref
Crossref
Harold E. Bays, Peter H. Jones, W. Virgil Brown & Terry A. Jacobson. (2014) National Lipid Association Annual Summary of Clinical Lipidology 2015. Journal of Clinical Lipidology 8:6, pages S1-S36.
Crossref
Crossref
David J. Portman, Andrew M. Kaunitz, Kazem Kazempour, Hana Mekonnen, Sailaja Bhaskar & Joel Lippman. (2014) Effects of low-dose paroxetine 7.5 mg on weight and sexual function during treatment of vasomotor symptoms associated with menopause. Menopause 21:10, pages 1082-1090.
Crossref
Crossref
Kirsten M. Fiest, Scott B. Patten, K. Chelsea Altura, Andrew G.M. Bulloch, Colleen J. Maxwell, Samuel Wiebe, Sophia Macrodimitris & Nathalie Jetté. (2014) Patterns and frequency of the treatment of depression in persons with epilepsy. Epilepsy & Behavior 39, pages 59-64.
Crossref
Crossref
Per Wändell, Gunnar Ljunggren, Lars Wahlström & Axel C. Carlsson. (2014) Diabetes and psychiatric illness in the total population of Stockholm. Journal of Psychosomatic Research 77:3, pages 169-173.
Crossref
Crossref
Garry Egger & John Dixon. (2014) Beyond Obesity and Lifestyle: A Review of 21st Century Chronic Disease Determinants. BioMed Research International 2014, pages 1-12.
Crossref
Crossref
. 2014. Therapie Psychischer Erkrankungen. Therapie Psychischer Erkrankungen
1
91
.
Chittaranjan Andrade. (2013) Primary prevention of cardiovascular events in patients with major mental illness: a possible role for statins. Bipolar Disorders 15:8, pages 813-823.
Crossref
Crossref
Katie Smithwick Adams. (2013) Toolbox: Metabolic adverse effects of atypical antipsychotics. Mental Health Clinician 3:3, pages 115-118.
Crossref
Crossref
Brandon MansoorManivel RengasamyRobert HiltonGiovanna PortaJiayan HeAnthony SpiritoGraham J. EmslieTaryn L. MayesGregory ClarkeKaren Dineen WagnerWael ShamseddeenBoris BirmaherNeal RyanDavid Brent. (2013) The Bidirectional Relationship Between Body Mass Index and Treatment Outcome in Adolescents with Treatment-Resistant Depression. Journal of Child and Adolescent Psychopharmacology 23:7, pages 458-467.
Crossref
Crossref
Marco PozziSilvana BertellaDario CattaneoMassimo MolteniValentina PerroneCarla CarnovaleStefania AntoniazziEmilio ClementiSonia Radice. (2013) Are Non-Serious Adverse Reactions to Psychiatric Drugs Really Non-Serious?. Journal of Child and Adolescent Psychopharmacology 23:6, pages 394-400.
Crossref
Crossref
Isabella Savini, Maria Catani, Daniela Evangelista, Valeria Gasperi & Luciana Avigliano. (2013) Obesity-Associated Oxidative Stress: Strategies Finalized to Improve Redox State. International Journal of Molecular Sciences 14:5, pages 10497-10538.
Crossref
Crossref
Borwin Bandelow, Reinhard J. Boerner, Siegfried Kasper, Michael Linden, Hans-Ulrich Wittchen & Hans-Jürgen Möller. (2013) The Diagnosis and Treatment of Generalized Anxiety Disorder. Deutsches Ärzteblatt international.
Crossref
Crossref
Elizabeth K. Nousen, Juliana G. Franco & Elinor L. Sullivan. (2013) Unraveling the Mechanisms Responsible for the Comorbidity between Metabolic Syndrome and Mental Health Disorders. Neuroendocrinology 98:4, pages 254-266.
Crossref
Crossref
Prashant Tiwari, Rajnikant Panik, Arin Bhattacharya, Dheeraj Ahirwar & Anish Chandy. (2012) Evidences of possible side effects of neuroleptic drugs: A systematic review. Asian Pacific Journal of Reproduction 1:4, pages 330-336.
Crossref
Crossref